Letter to HRSA Urging Effective Administration of the 340B Drug Pricing Program


Excerpt: “Given the important role the 340B Program plays in our nation’s health care safety-net, it is critical that program rules be clear and consistent for all stakeholders. Unfortunately, the agency has faced significant impediments to appropriate oversight and enforcement given recent judicial decisions that, in effect, left the agency without broad rulemaking authority.”

To read a copy of the letter, click here.

Health (115th Congress)